Click here to get full coverage on DOE releases 2025 NEUP and NSUF funding - American Nuclear Society -- ANS

DOE releases 2025 NEUP and NSUF funding  American Nuclear Society -- ANS

DOE releases 2025 NEUP and NSUF funding - American Nuclear Society -- ANS

Click here to get full coverage on Neuphoria Therapeutics Inc. Financial Disclosures & SEC Filings - TradingView

Neuphoria Therapeutics Inc. Financial Disclosures & SEC Filings  TradingView

Neuphoria Therapeutics Inc. Financial Disclosures & SEC Filings - TradingView

Click here to get full coverage on Here's Why We're A Bit Worried About Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation - simplywall.st

Here's Why We're A Bit Worried About Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation  simplywall.st

Here's Why We're A Bit Worried About Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation - simplywall.st

Click here to get full coverage on Futuristic nuclear fuel shape mimics nature to dramatically improve performance - Idaho National Laboratory (.gov)

Futuristic nuclear fuel shape mimics nature to dramatically improve performance  Idaho National Laboratory (.gov)

Futuristic nuclear fuel shape mimics nature to dramatically improve performance - Idaho National Laboratory (.gov)

Click here to get full coverage on Here's Why We're Not At All Concerned With Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation - Yahoo Finance

Here's Why We're Not At All Concerned With Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation  Yahoo Finance

Here's Why We're Not At All Concerned With Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation - Yahoo Finance

Click here to get full coverage on Why Did NEUP Stock Surge 64% Today? - Stocktwits

Why Did NEUP Stock Surge 64% Today?  Stocktwits

Why Did NEUP Stock Surge 64% Today? - Stocktwits

Click here to get full coverage on Lynx1 Capital buys Neuphoria Therapeutics (NEUP) shares worth $3.28m - Investing.com

Lynx1 Capital buys Neuphoria Therapeutics (NEUP) shares worth $3.28m  Investing.com

Lynx1 Capital buys Neuphoria Therapeutics (NEUP) shares worth $3.28m - Investing.com

Click here to get full coverage on (NEUP) and the Role of Price-Sensitive Allocations - Stock Traders Daily

(NEUP) and the Role of Price-Sensitive Allocations  Stock Traders Daily

(NEUP) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Click here to get full coverage on NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition - MSN

NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition  MSN

NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition - MSN

Click here to get full coverage on Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 - GlobeNewswire

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3  GlobeNewswire

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 - GlobeNewswire

Click here to get full coverage on NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition - Stocktwits

NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition  Stocktwits

NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition - Stocktwits

Click here to get full coverage on Key facts: NEUP BNC210 Fails; SAD Halted, PTSD Paused; Q2 Loss $1.12 - TradingView

Key facts: NEUP BNC210 Fails; SAD Halted, PTSD Paused; Q2 Loss $1.12  TradingView

Key facts: NEUP BNC210 Fails; SAD Halted, PTSD Paused; Q2 Loss $1.12 - TradingView

Click here to get full coverage on Does This Valuation Of Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Imply Investors Are Overpaying? - simplywall.st

Does This Valuation Of Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Imply Investors Are Overpaying?  simplywall.st

Does This Valuation Of Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Imply Investors Are Overpaying? - simplywall.st

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on What is the current Price Target and Forecast for Neuphoria Therapeutics Inc. (NEUP) - Zacks Investment Research

What is the current Price Target and Forecast for Neuphoria Therapeutics Inc. (NEUP)  Zacks Investment Research

What is the current Price Target and Forecast for Neuphoria Therapeutics Inc. (NEUP) - Zacks Investment Research

Click here to get full coverage on Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions - Yahoo Finance

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions  Yahoo Finance

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions - Yahoo Finance

Click here to get full coverage on Neuphoria Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Neuphoria Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary  TradingView

Neuphoria Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Click here to get full coverage on Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process - Yahoo Finance

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process  Yahoo Finance

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process - Yahoo Finance

Click here to get full coverage on Neuphoria Therapeutics Inc. 3Q 2026: Revenue $0 EPS $(0.09) — 10-Q Summary - TradingView

Neuphoria Therapeutics Inc. 3Q 2026: Revenue $0 EPS $(0.09) — 10-Q Summary  TradingView

Neuphoria Therapeutics Inc. 3Q 2026: Revenue $0 EPS $(0.09) — 10-Q Summary - TradingView

Click here to get full coverage on NEUP Stock Price and Chart — NASDAQ:NEUP - TradingView

NEUP Stock Price and Chart — NASDAQ:NEUP  TradingView

NEUP Stock Price and Chart — NASDAQ:NEUP - TradingView

Click here to get full coverage on NEUP Stock Price, News & Analysis - Stock Titan

NEUP Stock Price, News & Analysis  Stock Titan

NEUP Stock Price, News & Analysis - Stock Titan

Click here to get full coverage on Should I buy Neuphoria Therapeutics Inc. (NEUP) - Zacks Investment Research

Should I buy Neuphoria Therapeutics Inc. (NEUP)  Zacks Investment Research

Should I buy Neuphoria Therapeutics Inc. (NEUP) - Zacks Investment Research

Click here to get full coverage on U.S. Department of Energy Announces $7 Million to Enhance University Nuclear Programs - Department of Energy (.gov)

U.S. Department of Energy Announces $7 Million to Enhance University Nuclear Programs  Department of Energy (.gov)

U.S. Department of Energy Announces $7 Million to Enhance University Nuclear Programs - Department of Energy (.gov)

Click here to get full coverage on Neuphoria Therapeutics Inc. (NEUP) reports earnings - qz.com

Neuphoria Therapeutics Inc. (NEUP) reports earnings  qz.com

Neuphoria Therapeutics Inc. (NEUP) reports earnings - qz.com

Click here to get full coverage on Going digital: Idaho students, engineers demonstrate first nuclear reactor digital twin - Idaho National Laboratory (.gov)

Going digital: Idaho students, engineers demonstrate first nuclear reactor digital twin  Idaho National Laboratory (.gov)

Going digital: Idaho students, engineers demonstrate first nuclear reactor digital twin - Idaho National Laboratory (.gov)

Click here to get full coverage on Neuphoria Therapeutics Inc. Completes Scheme of Arrangement for Bionomics Limited's Re-Domiciliation to the U.S. - Quiver Quantitative

Neuphoria Therapeutics Inc. Completes Scheme of Arrangement for Bionomics Limited's Re-Domiciliation to the U.S.  Quiver Quantitative

Neuphoria Therapeutics Inc. Completes Scheme of Arrangement for Bionomics Limited's Re-Domiciliation to the U.S. - Quiver Quantitative

Click here to get full coverage on Two Brothers With ADSS1 Myopathy: A Report of Clinical, Radiological, and Autopsy Findings - Wiley Online Library

Two Brothers With ADSS1 Myopathy: A Report of Clinical, Radiological, and Autopsy Findings  Wiley Online Library

Two Brothers With ADSS1 Myopathy: A Report of Clinical, Radiological, and Autopsy Findings - Wiley Online Library

Click here to get full coverage on UW-Madison engineers receive $3.6M in DOE nuclear research awards - College of Engineering | University of Wisconsin-Madison

UW-Madison engineers receive $3.6M in DOE nuclear research awards  College of Engineering | University of Wisconsin-Madison

UW-Madison engineers receive $3.6M in DOE nuclear research awards - College of Engineering | University of Wisconsin-Madison

Click here to get full coverage on Blue-Chip Earnings Push Dow to Fresh Record High - Schaeffer's Investment Research

Blue-Chip Earnings Push Dow to Fresh Record High  Schaeffer's Investment Research

Blue-Chip Earnings Push Dow to Fresh Record High - Schaeffer's Investment Research

Click here to get full coverage on Pathological features of inflammatory myopathy as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation - Wiley Online Library

Pathological features of inflammatory myopathy as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation  Wiley Online Library

Pathological features of inflammatory myopathy as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation - Wiley Online Library

Click here to get full coverage on Three MIT-led research teams win 2014 Department of Energy NEUP awards - MIT News

Three MIT-led research teams win 2014 Department of Energy NEUP awards  MIT News

Three MIT-led research teams win 2014 Department of Energy NEUP awards - MIT News

Click here to get full coverage on NSE students win NEUP awards - MIT News

NSE students win NEUP awards - MIT News

Click here to get full coverage on Prince Rupert Golf Course rolls out upscale dining for the public - The Northern View

Prince Rupert Golf Course rolls out upscale dining for the public  The Northern View

Prince Rupert Golf Course rolls out upscale dining for the public - The Northern View

Click here to get full coverage on Nuclear science and engineering graduate students win NEUP fellowships - MIT News

Nuclear science and engineering graduate students win NEUP fellowships  MIT News

Nuclear science and engineering graduate students win NEUP fellowships - MIT News

Click here to get full coverage on NEUP Q1 2026 Earnings: Surprise EPS Beat Highlights Cost Discipline Despite Pre-Revenue Status - Final Results - newsline.com

NEUP Q1 2026 Earnings: Surprise EPS Beat Highlights Cost Discipline Despite Pre-Revenue Status - Final Results  newsline.com

NEUP Q1 2026 Earnings: Surprise EPS Beat Highlights Cost Discipline Despite Pre-Revenue Status - Final Results - newsline.com

Click here to get full coverage on NEUP Q1 2026 Earnings: Surprise EPS Beat Highlights Cost Discipline Despite Pre-Revenue Status - Earnings Revision Upgrade - newsline.com

NEUP Q1 2026 Earnings: Surprise EPS Beat Highlights Cost Discipline Despite Pre-Revenue Status - Earnings Revision Upgrade  newsline.com

NEUP Q1 2026 Earnings: Surprise EPS Beat Highlights Cost Discipline Despite Pre-Revenue Status - Earnings Revision Upgrade - newsline.com

Click here to get full coverage on NEUP Q1 2026 Earnings: Significant EPS Beat Amidst Revenue Absence - Debt Analysis Report - newsline.com

NEUP Q1 2026 Earnings: Significant EPS Beat Amidst Revenue Absence - Debt Analysis Report  newsline.com

NEUP Q1 2026 Earnings: Significant EPS Beat Amidst Revenue Absence - Debt Analysis Report - newsline.com

Click here to get full coverage on NEUP Q1 2026 Earnings: EPS Surprises with 90.9% Beat Amid No Revenue - Negative Surprise Momentum - newsline.com

NEUP Q1 2026 Earnings: EPS Surprises with 90.9% Beat Amid No Revenue - Negative Surprise Momentum  newsline.com

NEUP Q1 2026 Earnings: EPS Surprises with 90.9% Beat Amid No Revenue - Negative Surprise Momentum - newsline.com

Click here to get full coverage on Neuphoria Therapeutics (NEUP) Edges Lower as Consolidation Continues Near Support - Growth ETF - newsline.com

Neuphoria Therapeutics (NEUP) Edges Lower as Consolidation Continues Near Support - Growth ETF  newsline.com

Neuphoria Therapeutics (NEUP) Edges Lower as Consolidation Continues Near Support - Growth ETF - newsline.com

Click here to get full coverage on Neuphoria Therapeutics (NEUP) Edges Lower Amid Consolidation Near Support - Sentiment Shift - newsline.com

Neuphoria Therapeutics (NEUP) Edges Lower Amid Consolidation Near Support - Sentiment Shift  newsline.com

Neuphoria Therapeutics (NEUP) Edges Lower Amid Consolidation Near Support - Sentiment Shift - newsline.com

Click here to get full coverage on NEUP Q1 2026 Earnings: EPS Surprises with 90.9% Beat Amid No Revenue - Earnings Revision Upgrade - newsline.com

NEUP Q1 2026 Earnings: EPS Surprises with 90.9% Beat Amid No Revenue - Earnings Revision Upgrade  newsline.com

NEUP Q1 2026 Earnings: EPS Surprises with 90.9% Beat Amid No Revenue - Earnings Revision Upgrade - newsline.com

Click here to get full coverage on Neuphoria Therapeutics (NEUP) Holds Steady Near Support – Can the Range Hold? - Fibonacci Arc - newsline.com

Neuphoria Therapeutics (NEUP) Holds Steady Near Support – Can the Range Hold? - Fibonacci Arc  newsline.com

Neuphoria Therapeutics (NEUP) Holds Steady Near Support – Can the Range Hold? - Fibonacci Arc - newsline.com

Click here to get full coverage on NEUP Q1 2026 Earnings: Narrowed Loss Surprises as Pre-Revenue Stage Continues - Revenue Per Share - newsline.com

NEUP Q1 2026 Earnings: Narrowed Loss Surprises as Pre-Revenue Stage Continues - Revenue Per Share  newsline.com

NEUP Q1 2026 Earnings: Narrowed Loss Surprises as Pre-Revenue Stage Continues - Revenue Per Share - newsline.com

Click here to get full coverage on Neuphoria Therapeutics (NEUP) Slips Amid Sector Headwinds – Key Support Levels in Focus - Dark Pool Sentiment - The Legal Advocate

Neuphoria Therapeutics (NEUP) Slips Amid Sector Headwinds – Key Support Levels in Focus - Dark Pool Sentiment  The Legal Advocate

Neuphoria Therapeutics (NEUP) Slips Amid Sector Headwinds – Key Support Levels in Focus - Dark Pool Sentiment - The Legal Advocate

Click here to get full coverage on How sustainable is Neuphoria Therapeutics (NEUP) earnings momentum | Q1 2026: Better Than Expected - ROE Trend Analysis - newsline.com

How sustainable is Neuphoria Therapeutics (NEUP) earnings momentum | Q1 2026: Better Than Expected - ROE Trend Analysis  newsline.com

How sustainable is Neuphoria Therapeutics (NEUP) earnings momentum | Q1 2026: Better Than Expected - ROE Trend Analysis - newsline.com

Click here to get full coverage on How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05 - Safe Entry Stocks - newsline.com

How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05 - Safe Entry Stocks  newsline.com

How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05 - Safe Entry Stocks - newsline.com

Click here to get full coverage on Why Neuphoria Therapeutics (NEUP) Just Dropped -6.89% — What to Watch 2026-05-17 - Outside Reversal - newsline.com

Why Neuphoria Therapeutics (NEUP) Just Dropped -6.89% — What to Watch 2026-05-17 - Outside Reversal  newsline.com

Why Neuphoria Therapeutics (NEUP) Just Dropped -6.89% — What to Watch 2026-05-17 - Outside Reversal - newsline.com

Click here to get full coverage on NEUP Stock Analysis: Neuphoria Therapeutics gains 7.04 percent to hit 4.41 mark - newsline.com

NEUP Stock Analysis: Neuphoria Therapeutics gains 7.04 percent to hit 4.41 mark  newsline.com

NEUP Stock Analysis: Neuphoria Therapeutics gains 7.04 percent to hit 4.41 mark - newsline.com

Click here to get full coverage on Is Neuphoria Therapeutics (NEUP) Stock a Top Performer | Price at $4.36, Down 1.25% - NHNL Divergence - newsline.com

Is Neuphoria Therapeutics (NEUP) Stock a Top Performer | Price at $4.36, Down 1.25% - NHNL Divergence  newsline.com

Is Neuphoria Therapeutics (NEUP) Stock a Top Performer | Price at $4.36, Down 1.25% - NHNL Divergence - newsline.com

Click here to get full coverage on How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05 - Call Dominated - newsline.com

How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05 - Call Dominated  newsline.com

How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05 - Call Dominated - newsline.com

Click here to get full coverage on NEUP Q1 2026 Earnings: Narrowed Loss Surprises as Pre-Revenue Stage Continues - Earnings Seasonality - The Legal Advocate

NEUP Q1 2026 Earnings: Narrowed Loss Surprises as Pre-Revenue Stage Continues - Earnings Seasonality  The Legal Advocate

NEUP Q1 2026 Earnings: Narrowed Loss Surprises as Pre-Revenue Stage Continues - Earnings Seasonality - The Legal Advocate

Click here to get full coverage on Neuphoria Therapeutics (NEUP) Edges Lower Amid Consolidation Near Support - Bollinger Band - The Legal Advocate

Neuphoria Therapeutics (NEUP) Edges Lower Amid Consolidation Near Support - Bollinger Band  The Legal Advocate

Neuphoria Therapeutics (NEUP) Edges Lower Amid Consolidation Near Support - Bollinger Band - The Legal Advocate

Click here to get full coverage on NEUP Q1 2026 Earnings: Narrowed Loss Surprises as Pre-Revenue Stage Continues - Geographic Revenue Trends - The Legal Advocate

NEUP Q1 2026 Earnings: Narrowed Loss Surprises as Pre-Revenue Stage Continues - Geographic Revenue Trends  The Legal Advocate

NEUP Q1 2026 Earnings: Narrowed Loss Surprises as Pre-Revenue Stage Continues - Geographic Revenue Trends - The Legal Advocate

Click here to get full coverage on NEUP Stock Moves Higher as Traders Focus on Neuphoria’s Cash Runway - Bez Kabli

NEUP Stock Moves Higher as Traders Focus on Neuphoria’s Cash Runway  Bez Kabli

NEUP Stock Moves Higher as Traders Focus on Neuphoria’s Cash Runway - Bez Kabli

Click here to get full coverage on What Neuphoria Therapeutics (NEUP)'s +1.62% Jump Means for Investors 2026-05-21 - Wave Extension - The Legal Advocate

What Neuphoria Therapeutics (NEUP)'s +1.62% Jump Means for Investors 2026-05-21 - Wave Extension  The Legal Advocate

What Neuphoria Therapeutics (NEUP)'s +1.62% Jump Means for Investors 2026-05-21 - Wave Extension - The Legal Advocate

Click here to get full coverage on Neuphoria Receives Milestone Revenue From Pfizer KAT6 Trial - TipRanks

Neuphoria Receives Milestone Revenue From Pfizer KAT6 Trial  TipRanks

Neuphoria Receives Milestone Revenue From Pfizer KAT6 Trial - TipRanks

Click here to get full coverage on How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05 - Fund Manager Survey - The Legal Advocate

How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05 - Fund Manager Survey  The Legal Advocate

How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05 - Fund Manager Survey - The Legal Advocate

Click here to get full coverage on Neuphoria Therapeutics Inc. (NEUP) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Neuphoria Therapeutics Inc. (NEUP) Stock Forecast & Price Prediction 2026–2030  CoinCodex

NEUP

Price Chart

Key Statistics

Technicals

About NEUP

Latest News

DOE releases 2025 NEUP and NSUF funding - American Nuclear Society -- ANS

Neuphoria Therapeutics Inc. Financial Disclosures & SEC Filings - TradingView

Here's Why We're A Bit Worried About Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation - simplywall.st

Advanced Charts

Top Gainers

Top Losers